Furthermore, GSTP1-1 has also been shown to bind and inhibit tumor necrosis factor receptor-associated factor 2 (TRAF2), an upstream activator of JNK, thus blocking the MAPK/JNK signaling cascade at multiple levels 29
How It Works Subcutaneous or intramuscular injection delivers GHK-Cu directly into the tissue, providing systemic distribution and allowing for localized treatment of specific areas when administered near target tissues
It is also being investigated in combination with other investigational or approved compounds , such as semaglutide (a GLP-1 receptor agonist), under the name CagriSema
Did you know that every Medicube product is dermatologically tested
Br J Pharmacol (2006) 149(6):66675
Neurons death was observed when these cells were incubated in the presence of lentivirus lytic peptide (LLP-1) that expresses the carboxy terminal cytoplasmic domain of gp41 from HIV-1